Product Information |
|
Registration Number |
DR-XY40517
|
Generic Name |
Docetaxel (as trihydrate)
|
Brand Name |
Newtaxel-A
|
Dosage Strength |
40 mg/mL
|
Dosage Form |
Solution For IV Injection
|
Classification |
Prescription Drug (RX)
|
Packaging |
USP Type I colorless vial x 0.5 mL
(active) + USP Type I colorless glass vial x 1.8 mL (diluent) (Box of 1's); and 80 mg/ 2 mL: USP Type I colorless vial x 2 mL (active) + USP Type I colorless glass vial x 7 mL (diluent) (Box of 1's)
|
Pharmacologic Category |
Antineoplastic
|
Manufacturer |
Korea United Pharm. Inc.
|
Country of Origin |
Korea
|
Trader |
|
Importer |
Qualimed Pharma Inc.
|
Distributor |
Qualimed Pharma Inc.
|
Application Type |
Renewal
|
Issuance Date |
04 August 2024
|
Expiry Date |
10 January 2030
|